Overview
Properties
Concentration information loading...Applications
Our Abpromise guarantee covers the use of ab7881 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| Blocking |
Protein info
-
Alternative names
- A disintegrin and metalloproteinase domain 17A disintegrin and metalloproteinase domain 17 (tumor necrosis factor, alpha, converting enzyme)ADA17_HUMAN
- ADAM 17ADAM metallopeptidase domain 17ADAM17ADAM17 proteinCD 156bCD156bCD156b antigenCSVPDisintegrin and metalloproteinase domain-containing protein 17MGC71942Snake venom like proteaseSnake venom-like proteaseTACETNF alpha convertaseTNF alpha converting enzymeTNF-alpha convertaseTNF-alpha-converting enzymeTumor Necrosis Factor Alpha Converting Enzyme
see all
Contains 1 peptidase M12B domain.
The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.
modificationsThe precursor is cleaved by a furin endopeptidase.
Phosphorylated. Stimulation by growth factor or phorbol 12-myristate 13-acetate induces phosphorylation of Ser-819 but decreases phosphorylation of Ser-791.
Target information above from: UniProt accession
P78536
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
References for ADAM17 peptide (ab7881)
ab7881 has not yet been referenced specifically in any publications.